Corvus Pharmaceuticals, Inc. (CRVS) stock
CRVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.17−0.43 (-4.06%)
Close on Nov 17, 2026Market cap $855.51MP/E –Yield –
Corvus Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Corvus Pharmaceuticals's price to book ratio was 4.3× on Nov 11, 2026, against 9.5× a year earlier. Over the last 5 years it ranged from 0.5× to 45.8×, with a median of 3.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.3× | −3.7 |
| 2025 | Dec 31, 2025 | 8.0× | −19.0 |
| 2024 | Dec 31, 2024 | 27.0× | +25.0 |
| 2023 | Dec 29, 2023 | 1.9× | +1.3 |
| 2022 | Dec 30, 2022 | 0.6× | −0.5 |
| 2021 | Dec 31, 2021 | 1.1× | −1.3 |
| 2020 | Dec 31, 2020 | 2.4× | +0.4 |
| 2019 | Dec 31, 2019 | 2.0× | +1.1 |
| 2018 | Dec 31, 2018 | 0.9× | −1.4 |
| 2017 | Dec 29, 2017 | 2.3× | +0.2 |
| 2016 | Dec 30, 2016 | 2.1× | – |
See a number that looks wrong?